
Abivax SA: shareholders and insiders
Price
$73.20
November 20, 2026Market cap $5.7B
What Ploutos Investor adds for Abivax SA
Part of Ploutos Investor, €9.99 a month
- The full history: 5 fiscal years, from 2021
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Insiders and their shares
Purchases and sales by officers and directors, from their own Form 4 filings.
Sorry, we do not have enough data
for purchases and sales by Abivax SA's insiders
Why?
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- TCG Crossover GP I, LLCwith 4 more personsShare of class7.00%
- Invus Public Equities, L.P.with 7 more personsShare of class6.00%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| TCG Crossover GP I, LLCwith 4 more persons | 7.00% | 6.01M | Aug 14, 20262 filings since Nov 14, 2025 | 13G/A | |
| Invus Public Equities, L.P.with 7 more persons | 6.00% | 4.83M | Aug 13, 20263 filings since Apr 11, 2025 | 13G/A |
Fell to 5% or less (3)
Holders whose latest filing says they hold 5% or less. After it they need not file again, so what they hold today is not known.
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter-9.0%
- Point72 (Cohen)In the quarter×55.7
- Millennium Mgmt (Englander)In the quarter+78%
- D.E. ShawIn the quarter-52%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 1.31M | -9.0% | $130M | 0.07% |
| Point72 (Cohen) | 280.2K | ×55.7 | $28M | 0.04% |
| Millennium Mgmt (Englander) | 416.6K | +78% | $41M | 0.03% |
| D.E. Shaw | 43.8K | -52% | $4.3M | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short sales in daily trading
How much of the shares that changed hands were short sales, in the off-exchange trades brokers report each day.
In the last 14 sessions, 36.0% of the shares in the reported trades were short sales, against 36.0% in the 14 before.
- Last 14 sessionsNov 3, 2026 – Nov 20, 2026
- 36.0%
- The 14 beforeOct 14, 2026 – Nov 2, 2026
- 36.0%
- Change
- +0.0 pts
- Short sales a dayon average, of 769.9K shares
- 277.2K
- More than atof 3,666 US-listed companies, same days
- 12%
- Median of alleight in ten from 34.4% to 63.9%
- 50.5%
- Short sales
- Oct 14, 2026: Short sales 38.4%
- Oct 15, 2026: Short sales 36.7%
- Oct 16, 2026: Short sales 50.6%
- Oct 19, 2026: Short sales 33.7%
- Oct 20, 2026: Short sales 31.9%
- Oct 21, 2026: Short sales 28.9%
- Oct 22, 2026: Short sales 49.9%
- Oct 23, 2026: Short sales 37.9%
- Oct 26, 2026: Short sales 37.2%
- Oct 27, 2026: Short sales 18.2%
- Oct 28, 2026: Short sales 47.9%
- Oct 29, 2026: Short sales 28.3%
- Oct 30, 2026: Short sales 28.7%
- Nov 2, 2026: Short sales 40.6%
- Nov 3, 2026: Short sales 40.2%
- Nov 4, 2026: Short sales 40.9%
- Nov 5, 2026: Short sales 23.7%
- Nov 6, 2026: Short sales 27.7%
- Nov 9, 2026: Short sales 20.3%
- Nov 10, 2026: Short sales 21.9%
- Nov 11, 2026: Short sales 27.1%
- Nov 12, 2026: Short sales 55.2%
- Nov 13, 2026: Short sales 47.5%
- Nov 16, 2026: Short sales 53.5%
- Nov 17, 2026: Short sales 52.9%
- Nov 18, 2026: Short sales 46.6%
- Nov 19, 2026: Short sales 55.5%
- Nov 20, 2026: Short sales 31.5%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half. Shares held short, which are published twice a month, are not included here.
The ETFs that hold it
Which of the 349 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IBBiShares Biotechnology ETFWeight in the fund0.67%
- EZUiShares MSCI Eurozone ETFWeight in the fund0.09%
- EFGiShares MSCI EAFE Growth ETFWeight in the fund0.07%
- IMTMiShares MSCI Intl Momentum Factor ETFWeight in the fund0.06%
- VGKVanguard European Stock Index FundWeight in the fund0.06%
- IEURiShares Core MSCI Europe ETFWeight in the fund0.05%
- GSIEGoldman Sachs ActiveBeta(R) International Equity ETFWeight in the fund0.03%
- EFAiShares MSCI EAFE ETFWeight in the fund0.03%
- DBEFXtrackers MSCI EAFE Hedged Equity ETFWeight in the fund0.03%
- IEFAiShares Core MSCI EAFE ETFWeight in the fund0.03%
23 of the 349 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 166
- Q4 2025: Managers 247
- Q1 2026: Managers 254
- Q2 2026: Managers 303
Institutional investors by quarter
The fund managers holding ABVX, quarter by quarter, from Q4 2023 to Q2 2025, 7 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 11 quarters.
Q2 2026: 303 managers held 55.08M shares, worth $7.2B. During the quarter 91 opened a position, 42 closed one, 97 added and 99 trimmed.
The largest holders, Q2 2026
- TCG Crossover ManagementIn the quarter-7.3%
- Darwin Global ManagementIn the quarter+4.4%
- Helikon InvestmentsIn the quarter+175%
- Vestal Point CapitalIn the quarter+57%
- Jupiter TopcoIn the quarter
- UBS GroupIn the quarter-59%
- ADAR1 Capital ManagementIn the quarter+29%
- Caligan PartnersIn the quarter+6.6%
- Citadel Advisors (Griffin)In the quarter+164%
- Morgan StanleyIn the quarter-16%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| TCG Crossover Management | 6.01M | -7.3% | $801M |
| Darwin Global Management | 3.62M | +4.4% | $348M |
| Helikon Investments | 2.79M | +175% | $371M |
| Vestal Point Capital | 2.35M | +57% | $313M |
| Jupiter Topco | 1.91M | $255M | |
| UBS Group | 1.84M | -59% | $246M |
| ADAR1 Capital Management | 1.80M | +29% | $240M |
| Caligan Partners | 1.56M | +6.6% | $208M |
| Citadel Advisors (Griffin) | 1.44M | +164% | $192M |
| Morgan Stanley | 1.43M | -16% | $191M |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Abivax SA's filings show?
Who buys and sells is one part of Abivax SA's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have ABVX's insiders bought or sold?
From – to – Abivax SA's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold ABVX?
4 of the managers we track held the shares on Sep 30, 2026. The largest position was Citadel Advisors (Griffin)'s, worth $130M.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.